Skip To Main Content

Utbildning

Sort by

Filtera

Återställ
  • Filtera
Understanding Cardiovascular Risk and Prevention: Insights from Professor Pasquale Perrone-Filardi

Understanding Cardiovascular Risk and Prevention: Insights from Professor Pasquale Perrone-Filardi

Preventive Cardiology: Key Insights from Professor Michal Vrablik

Preventive Cardiology: Key Insights from Professor Michal Vrablik

Personalized approach in T2D is key for success

Personalized approach in T2D is key for success

The Sanofi webinar ‘Act Now for Impact: Glycemic Control and Beyond’ focuses on recent advancements in treating type 2 diabetes (T2D), emphasizing a personalized approach for better outcomes. Prof. Frank Nobels (Belgium), prof. De Galan (the Netherlands) and Prof Björn Eliasson (Sweden) addressed various aspects of T2D treatment in the present era.

A phase III randomized trial evaluating alirocumab 300 mg every 4 weeks as monotherapy or add-on to statin: ODYSSEY CHOICE I

A phase III randomized trial evaluating alirocumab 300 mg every 4 weeks as monotherapy or add-on to statin: ODYSSEY CHOICE I

Roth Eli M et al. Atherosclerosis vol. 254 (2016): 254-262

Introduction to hand and foot dermatitis

Introduction to hand and foot dermatitis

Hot topics in atopic dermatitis: Hear it from the experts

Hot topics in atopic dermatitis: Hear it from the experts

Instruktionsfilmer för förberedelse och infusion av Fabrazyme

Instruktionsfilmer för förberedelse och infusion av Fabrazyme

Why Don’t We Strike Early, Strike Strong?

Why Don’t We Strike Early, Strike Strong?

Prof. Dr. Halvorsen, Prof. Dr. Sinnaeve & Prof. Dr. Martens

COPD Research Forum

COPD Research Forum

In this COPD Research Forum, leading healthcare professionals discuss critical topics such as IL-33, lung function trajectories, and mucus plugging in COPD.

Rhino Rounds International 2024 - Interview

Rhino Rounds International 2024 - Interview

Highlights från ERS 2024, Wien, 7-11 september

Highlights från ERS 2024, Wien, 7-11 september

Symposierapporter Sanofi

Sanofi har med hjälp av AI-verktyg förkortat texterna till sammanfattningar samt översatt dem till svenska.

Slowly Expanded Lesions

Slowly Expanded Lesions

A candidate biomarker for smoldering neuroinflammation in MS.